177 related articles for article (PubMed ID: 24724369)
1. [Cardiomyopathy: progress in diagnosis and treatments. Topics: II. Secondary cardiomyopathy; 1. Cardiac Fabry disease].
Kubo T
Nihon Naika Gakkai Zasshi; 2014 Feb; 103(2):293-8. PubMed ID: 24724369
[No Abstract] [Full Text] [Related]
2. The Fabry cardiomyopathy - diagnostic approach and current treatment.
Weidemann F; Ertl G; Wanner C; Krämer J
Curr Pharm Des; 2015; 21(4):473-8. PubMed ID: 25483948
[TBL] [Abstract][Full Text] [Related]
3. [Cardiomyopathy: progress in diagnosis and treatments. Topics: III. Diagnosis leading to selection of therapy; 1. Patient history, symptom and physical findings of cardiomyopathy].
Sakamoto N; Yoshihisa A; Takeishi Y
Nihon Naika Gakkai Zasshi; 2014 Feb; 103(2):336-44. PubMed ID: 24724374
[No Abstract] [Full Text] [Related]
4. [Chinese expert consensus on the diagnosis and treatment of adult Fabry disease cardiomyopathy].
;
Zhonghua Xin Xue Guan Bing Za Zhi; 2024 Feb; 52(2):128-136. PubMed ID: 38326063
[TBL] [Abstract][Full Text] [Related]
5. Role of cardiac imaging in Anderson-Fabry cardiomyopathy.
Serra W; Marziliano N
Cardiovasc Ultrasound; 2019 Jan; 17(1):1. PubMed ID: 30674321
[TBL] [Abstract][Full Text] [Related]
6. [Cardiomyopathy: progress in diagnosis and treatments. Topics: II. Secondary cardiomyopathy; 2. Cardiac sarcoidosis].
Tezuka D; Isobe M
Nihon Naika Gakkai Zasshi; 2014 Feb; 103(2):299-308. PubMed ID: 24724370
[No Abstract] [Full Text] [Related]
7. Physiologic or pathologic hypertrophy: how can we know?
Lai EJ; Rakowski H
Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):919-22. PubMed ID: 24972675
[TBL] [Abstract][Full Text] [Related]
8. [Cardiological follow-up in patients with Fabry disease].
Pieruzzi F; Pieroni M; Chimenti C; Frustaci A; Sarais C; Cecchi F;
G Ital Cardiol (Rome); 2010; 11(7-8):566-72. PubMed ID: 21033333
[TBL] [Abstract][Full Text] [Related]
9. Guidelines to diagnosis and monitoring of Fabry disease and review of treatment experiences.
Martins AM; D'Almeida V; Kyosen SO; Takata ET; Delgado AG; Gonçalves AM; Benetti Filho CC; Martini Filho D; Biagini G; Pimentel H; Abensur H; Guimarães HC; Gomes JG; Sobral Neto J; D'Almeida LO; Carvalho LR; Harouche MB; Maldonado MC; Nascimento OJ; Montoril PS; Bastos RV
J Pediatr; 2009 Oct; 155(4 Suppl):S19-31. PubMed ID: 19765408
[No Abstract] [Full Text] [Related]
10. Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment.
Niemann M; Herrmann S; Hu K; Breunig F; Strotmann J; Beer M; Machann W; Voelker W; Ertl G; Wanner C; Weidemann F
JACC Cardiovasc Imaging; 2011 Jun; 4(6):592-601. PubMed ID: 21679893
[TBL] [Abstract][Full Text] [Related]
11. Pathology and function of conduction tissue in Fabry disease cardiomyopathy.
Frustaci A; Morgante E; Russo MA; Scopelliti F; Grande C; Verardo R; Franciosa P; Chimenti C
Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):799-805. PubMed ID: 26047621
[TBL] [Abstract][Full Text] [Related]
12. [Cardiomyopathy: progress in diagnosis and treatments. Topics: IV. Selection of therapy for improvement of prognosis and QOL; 2. Cardiac resynchronization therapy].
Okamura H; Kusano K
Nihon Naika Gakkai Zasshi; 2014 Feb; 103(2):387-92. PubMed ID: 24724379
[No Abstract] [Full Text] [Related]
13. Early detection of Fabry cardiomyopathy by tissue Doppler imaging.
Pieroni M; Chimenti C; Ricci R; Sale P; Russo MA; Frustaci A
Circulation; 2003 Apr; 107(15):1978-84. PubMed ID: 12668521
[TBL] [Abstract][Full Text] [Related]
14. Fabry cardiomyopathy: what could parametric mapping still unveil?
Oliveira L; Brito D; Abecasis J
Rev Esp Cardiol (Engl Ed); 2022 Mar; 75(3):262-263. PubMed ID: 34742671
[No Abstract] [Full Text] [Related]
15. Cardiovascular magnetic resonance assessment of ischemic and nonischemic cardiomyopathies.
Raney AR; Bello D
Heart Fail Clin; 2006 Apr; 2(2):145-61. PubMed ID: 17386886
[No Abstract] [Full Text] [Related]
16. [Cardiomyopathy: progress in diagnosis and treatments. Topics: II. Secondary cardiomyopathy; 5. Noncompaction of the ventricular myocardium].
Ichida F
Nihon Naika Gakkai Zasshi; 2014 Feb; 103(2):327-35. PubMed ID: 24724373
[No Abstract] [Full Text] [Related]
17. Anderson-Fabry disease: a cardiomyopathy that can be cured.
Anastasakis A; Sevdalis E; Papatheodorou E; Stefanadis C
Hellenic J Cardiol; 2011; 52(4):316-26. PubMed ID: 21933763
[No Abstract] [Full Text] [Related]
18. Case 5: 50-year-old woman with restrictive cardiomyopathy, renal failure and proteinuria.
Silvestre OM; Ribeiro HB; Paula LJ; Macêdo SR; Castelli JB
Arq Bras Cardiol; 2009 Nov; 93(5):569-77. PubMed ID: 20084321
[No Abstract] [Full Text] [Related]
19. [Cardiomyopathy: progress in diagnosis and treatments. Topics: III. Diagnosis leading to selection of therapy: 2. Biomarker].
Onoue K; Nakano T; Saito Y
Nihon Naika Gakkai Zasshi; 2014 Feb; 103(2):345-52. PubMed ID: 24724375
[No Abstract] [Full Text] [Related]
20. [Guidelines for diagnosis, monitoring and treatment of Fabry disease].
; Neumann P; Antongiovanni N; Fainboim A; Kisinovsky I; Amartino H; Cabrera G; Carmona S; Ceci R; Cicerán A; Choua M; Doxastakis G; De Maio S; Ebner R; Escobar AM; Ferrari G; Forrester M; Guelbert N; Luna P; Marchesoni C; Masllorens F; Politei J; Reisin R; Ripeau D; Rozenfeld P; Serebrinsky G; Tarabuso AL; Trípoli J
Medicina (B Aires); 2013; 73(5):482-94. PubMed ID: 24152410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
